Dermadry Wins Startup Innovation Award at the 31st ADRIQ Innovation Awards Gala
MONTREAL, December 3, 2021 (Newswire.com) - Dermadry, a Montreal-based medical device company dedicated to development of iontophoresis technology for the treatment of hyperhidrosis, is proud to announce that they are the recipients of the Startup Award at the 2021 Innovation Awards presented by the Association pour le Développement de la Recherche et de l'Innovation du Québec (ADRIQ).
The ADRIQ gala rewards Quebec-based companies for leadership in innovation in their respective field. The ADRIQ's 31st Innovation Awards Gala, viewed as Québec's innovation community's most prestigious event, was held virtually on Nov. 25, 2021.The Innovation - Jeune Entreprise award is presented every year to a company that has recently developed and introduced a daring innovation to the market. This prize serves to highlight the technical creativity and capacity of Québécois startup companies.
This prestigious juried gala brings together exceptional and successful innovators across the province of Québec. As a proudly Québecois company headquartered in Montréal, Dermadry is honored to have received this award. The Gala can be watched by clicking here, and Dermadry's award is presented by Dr. Paula Wood-Adams, Interim VP, Research and Graduate Studies at Concordia University.
"When we started this company a few years ago, it was to help people suffering from excessive sweating of the hands, feet, and underarms. It's a dream come true. It wouldn't be possible without our partners, and our team who helps those living with hyperhidrosis every single day. Winning this prize is a great motivator to continue our innovative efforts and work on new technologies to further help the millions of people worldwide living with this condition," said Mathieu Mireault, Dermadry's Director of Sales, upon proudly accepting the award during the virtual gala.
About Dermadry
Dermadry is dedicated to empowering individuals who are affected by excessive sweating, a medical condition known as hyperhidrosis that affects approximately 1 in 20 people worldwide.
Dermadry's iontophoresis machine distinguishes itself through its affordability, intuitive use, and its cutting-edge technology.
Dermadry strives to improve the visibility and viability of iontophoresis treatment in the public and medical spheres so that more people suffering from this common medical condition have a safe, effective, non-invasive treatment option at their fingertips. Dermadry's research and development team is dedicated to developing new technologies, features, and products to enable more people globally to live comfortably and confidently sweat-free.
Stay up-to-date with Dermadry's news and developments by subscribing to their newsletter on their website and following them across social media @dermadry.
Source: Dermadry